SRx Health (SRXH) commits >10% investable capital to AI and space via Astro
Rhea-AI Filing Summary
SRx Health Solutions, Inc. announced that its wholly owned subsidiary, Halo, Purely for Pets, Inc., has invested more than 10% of the company’s aggregate treasury assets in Astro Investment XVII, an affiliate of Astro Capital structured as a special purpose vehicle.
The company and EMJ Crypto Technologies highlighted that this represents an investment of greater than 10% of their investable capital, targeting opportunities at the intersection of artificial intelligence and space-related businesses. The disclosure also notes that SRx has filed a Registration Statement on Form S-4 covering common stock to be issued in its previously announced merger with EMJX, with an information statement/prospectus to be sent to stockholders after effectiveness.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Regulation FD regulatory
treasury assets financial
special purpose vehicle (SPV) financial
Registration Statement on Form S-4 regulatory
Information Statement/Prospectus regulatory
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in its Charter)
(State or other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(Registrant’s
Telephone Number, Including Area Code):
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
On April 22, 2026, SRx Health Solutions, Inc. (the “Company”) announced that its wholly owned subsidiary, Halo, Purely for Pets, Inc., made an investment in Astro Investment XVII, an affiliate of Astro Capital. The amount of the investment is greater than 10% of the Company’s aggregate treasury assets. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibits | Description | |
| 99.1 | Press Release, dated April 22, 2026. | |
| 104 | Cover Page Interactive Data File (Embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| April 22, 2026 | SRx Health Solutions, Inc. | |
| By: | /s/ Carolina Martinez | |
| Name: | Carolina Martinez | |
| Title: | Chief Financial Officer | |
Exhibit 99.1
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital
Company has invested greater than 10 % of its investable capital in the convergence of Artificial Intelligence (“AI”) and space through Astro Capital
NORTH PALM BEACH, FL — April 22, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced it has made an investment of greater than 10% of its investable capital in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle (SPV).
For more information please visit, Astro Capital.
“This investment demonstrates our belief in the long-term value of both AI and space,” said Eric. M. Jackson, EMJX Founder & Chief Executive Officer. “Astro Capital provides an avenue to invest in these high potential growth areas, and we are excited about the opportunities this will present for our shareholders.”
Additional Information and Where to Find It
In connection with the proposed transaction between the Company and EMJX, the Company has filed with the SEC a Registration Statement on Form S-4 (the “Registration Statement”) to register the common stock to be issued in connection with the proposed transaction. The Registration Statement includes an information statement of the Company and a prospectus of the Company (the “Information Statement/Prospectus”), and each of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders This is not a substitute for the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY READ THE REGISTRATION STATEMENT AND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus, as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available, at the SEC’s website at www.sec.gov. The information on EMJX’s or the Company’s respective websites is not, and shall not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.
No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.
Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer
Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com